Targeted inhibition of Aurora kinase A promotes immune checkpoint inhibition efficacy in human papillomavirus-driven cancers is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Clinical Center
Grant: National Institutes of Health R01CA248205
UTHealth Houston’s Center for Clinical and Translational Sciences TL1 Program
Grant: TL1TR003169
Center for Information Technology
Grant: P30CA016672
NCI NIH HHS
Grant: R01 CA248205
National Institutes of Health
Grant: 5R01CA248205-02
Harnessing Aurora kinase inhibition‐induced cell death to enhance immunotherapy in HPV‐driven cancers
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5TL1TR003169-02
NRSA Training Core
FWCI
6.12
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals